Imperial Valley News
Dallas, Texas - Deaths from heart disease have declined dramatically over the last few decades but young people, particularly women, are not sharing equally in that improvement, according to new research in the American Heart Association’s journal Circulation.
Atlanta, Georgia - Patients who have to travel farther to appointments are less likely to receive adjuvant chemotherapy (given after surgery to reduce the chance of the cancer returning), regardless of whether or not they are insured, according to a new study conducted in collaboration between the American Cancer Society, American Society of Clinical Oncology (ASCO), and the American Society for Radiation Oncology (ASTRO). The study appears early online in the Journal of Clinical Oncology.
American Cancer Society and MyLifeLine.org Partner to Provide Cancer Focused Social Support Services
Washington, DC - The American Cancer Society and MyLifeLine.org Cancer Foundation (MyLifeLine.org) are pleased to announce a new partnership to provide social and emotional support services to all people affected by cancer. The American Cancer Society is the latest nonprofit partner in MyLifeLine.org’s eight-year history.
Chicago, Illinois - The problem of burnout and caregiver fatigue among physicians is real and immediate. In fact, research shows that the rates of overall burnout extend to about 40 percent of U.S. physicians, more than 10 percentage points higher than the general population. In response, the American Medical Association (AMA) has created an ambitious program aimed at successfully preventing burnout and promoting well-being for medical professionals.
Washington, DC - The U.S. Food and Drug Administration today approved Promacta (eltrombopag) to treat low blood platelet count in pediatric patients – ages one year and older – with a rare blood disorder called chronic immune thrombocytopenic purpura (ITP). Promacta can be used in these children when they have not achieved an appropriate response using other ITP medicines or surgery to remove the spleen.
Washington, DC - While some research suggests that a diet high in omega-3 fatty acids can protect brain health, a large clinical trial by researchers at the National Institutes of Health found that omega-3 supplements did not slow cognitive decline in older persons. With 4,000 patients followed over a five-year period, the study is one of the largest and longest of its kind. It was published today in the Journal of the American Medical Association.